The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile

Tahar Chakroun; Grigoris T. Gerotziafas; Jerhad Seghatchian; Meyer M. Samama; Mohamed Hatmi; Ismail Elalamy

doi:10.1160/TH05-07-0500

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 95(05): 822-828
DOI: 10.1160/TH05-07-0500

Platelets and Blood Cells

Schattauer GmbH

The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile

Tahar Chakroun

¹Service d’Hématologie Biologique Hôtel-Dieu de Paris, Paris, France

,

Grigoris T. Gerotziafas

¹Service d’Hématologie Biologique Hôtel-Dieu de Paris, Paris, France

,

Jerhad Seghatchian

²Blood component technology and haemostasis / thrombosis consultancy, London, United Kingdom

,

Meyer M. Samama

¹Service d’Hématologie Biologique Hôtel-Dieu de Paris, Paris, France

,

Mohamed Hatmi

¹Service d’Hématologie Biologique Hôtel-Dieu de Paris, Paris, France

³Département de Médecine Moléculaire, Institut Pasteur Paris, Paris, France

,

Ismail Elalamy

¹Service d’Hématologie Biologique Hôtel-Dieu de Paris, Paris, France

› Author Affiliations

Abstract

Summary

Thromboelastography analysis providing a global assessment of coagulation is gaining new interest in clinical practice. Minimal TF triggered whole blood thromboelastography provides a valuable tool for studying the kinetics of clot formation (expressed by the parameters R, K and α-angle) and the physical characteristics of the clot, such as its firmness and the elastic modulus shear (expressed by the parameters maximal amplitude MA and G). We studied the influence of fibrin polymerization and platelet functional status on each parameter of thromboelastographic trace obtained by minimal TF activation in WB by employing increasing concentrations of a fibrin polymerization inhibitors (the tetrapeptide Gly-Pro-Arg-Pro-OH. AcOH; Pefabloc-FG^®) and an inhibitor of actin polymerization (Cytochalasin D). Pefabloc-FG^® at concentrations higher than 5 mg/ml prolonged the R and K times and decreased the α-angle in a concentration-dependent manner but it did not modify MA and G parameters. At the concentration of 5 mg/ml, Pefabloc-FG^® completely inhibited clot formation. Cytochalasin D had no effect on R time but decreased the α-angle, MA and G parameters by reachinga plateau at the concentration of 5 µM. The effect of cytochalasin D was more pronounced on MA and G than on the α-angle. A combination of both Pefabloc-FG^® (0.5 mg/ml) and cytochalasin D (50 µM) significantly decreased α-angle compared to control as well as their single effect. However, G value was dramatically reduced in the presence of cytochalasin D exposure, without any additional effect when both inhibitors were combined. This study confirms the importance of fibrin polimerization on the kinetics of thrombus formation and demonstrates the close association between the quality of the thrombus and the functional status of platelets. Normal platelet contractile forces are of major importance for the maximum amplitude of TEG which is related to the strength and elastic modulus of the thrombus.

Keywords

Fibrin polymerization - cytochalasin D - platelet-contractility - thromboelastography - TEG^®

Full Text

References

References
1 Hartert H. Blutgerinnungessstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klien Wochenschr 1948; 26: 577-83.
2 Marchal G, Leroux ME, Samama MM. Interêt de thrombodynamographie (Thromboelastographie) dans l’étude des syndromes hémorragiques. Pat Biol 1958; 951-3.
3 Kang YG, Martin DJ, Marquez J. et al. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 1985; 64: 888-96.
4 Tuman KJ, McCarthy RJ, Djuric M. et al. Evaluation of coagulation during cardiopulmonary bypass with heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth 1994; 08: 144-9.
5 Shore-Lesserson HEManspeizer, DePerio M. et al. Thromboelastography-guided transfusion algorithm reduces transfusion in complex cardiac surgery. Anesth Analg 1999; 88: 312-9.
6 Marchal G, Leroux ME, Samama MM. The principal and techniques of thrombodynamography. In: Atlas of Thrombodynamography. Marchal G, Leroux ME, Samama MM. eds. Haemoscope Corporation; 2003: 1-22.
7 Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg 2000; 90: 1086-8.
8 Gerotziafas GT, Chakroun T, Samama MM. et al. In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood thromboelastography profile employing minimal tissue factor pathway activation. Thromb Haemost 2004; 92: 1296-1302.
9 Greilich PE, Alving BM, O’Neill KL. et al. A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients. Anesth Analg 1997; 84: 31-8.
10 Gottumukkala VN, Sharma SK, Philip J. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth Analg 1999; 89: 1435-55.
11 Mahla E, Lang T, Vicenzi MN. et al. Thromboelastography for monitoring prolonged hypercoagulability after abdominal surgery. Anesth Analg 2001; 92: 572-7.
12 Lorand L, Parameswaran KN, Murthy SNP. A double-heated Gly-Pro-Arg-Pro ligands mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of chains by factor XIIIa. Biochemistry 1998; 95: 537-41.
13 Laudano AP, Doolittle RF. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 1980; 19: 1013-9.
14 Cassela JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature 1981; 293: 302-5.
15 Bennet JS, Zigmond S, Vilaire G. et al. The platelet cytoskeleton regulates the affinity of the integrin aIIbß3 of fibrinogen. J Biol Chem 1999; 274: 25301-7.
16 Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem 1999; 274: 22862-70.
17 Hsieh KH. Thrombin interaction with fibrin polymerization sites. Thromb Res 1997; 86: 301-16.
18 Morgenstern E, Ruf A, Patscheke H. Ultrastructure of the interaction between human platelets and polymerizing fibrin within the first minutes of clot formation. Blood Coagul Fibrinolysis 1990; 01: 543-6.
19 Brown RS, Niewiarowski S, Stewart GJ. et al. A double-isotope study on incorporation of platelets and red cells into fibrin. J Lab Clin Med 1977; 90: 130-40.
20 Hantgan RR, Hindriks G, Taylor RG. et al. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990; 76: 345-53.
21 Khurana S, Mattson JC, Westley S. et al. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997; 130: 401-11.
22 Nielsen VG, Gurley Jr WQ, Burch TM. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 2004; 99: 120-3.
23 Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA 1978; 75: 3085-9.
24 Sorensen B, Johensen P, Christiansen K. et al. Whole blood coagulation thromboelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 01: 551-8.
25 Cerecedo D, Stock R, Gonzalez S. et al. Modification of actin, myosin and tubulin distribution during cytoplasmic granule movements associated with platelet adhesion. Haematologica 2002; 87: 1165-76.
26 Gerotziafas GT, Chakroun T, Elalamy I. et al. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation after TF pathway activation in human plasma. Thromb Haemost 2004; 91: 977-85.
27 Kettner SC, Panzer OP, Kozek SA. et al. Use of abciximab-modified thromboelastography in patient undergoing cardiac surgery. Anesth Analg 1999; 89: 580-4.
28 Chon I, Burk DL, White JG. The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb/IIIa complex on the development of clot tension. Blood 1989; 73: 1880-7.
29 Osdoit S, Rosa JP. Fibrin clot retraction by human platelets correlates with αIIbβ3 integrin-dependent protein tyrosin dephosphorylation. J Biol Chem 2001; 276: 6703-10.
30 Lang T, Toller W, Gütl M. et al. Different effects of abciximab and cytochalasin D on clot strength in thromboelastography. J Thromb Haemost 2004; 02: 1-7.
31 Olorundare OE, Simmons SR, Albrecht RM. CytochalasinD and E: effect on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets:a correlative light and electron microscopic investigation. Blood 1992; 79: 99-109.
32 Reverter JC, Béguin S, Kessels H. et al. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. J Clin Invest 1996; 98: 863-74.
33 Ni N, Kevil CG, Bullard DC. et al. Avidity modulation activates adhesion under flow and requires cooperativity among adhesion receptors. Biophys J 2003; 85: 4122-33.
34 Nakano T, Hanasaki K, Arita H. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets. J Biol Chem 1989; 10: 5400-6.